Project Grant HT94252410823
Award Date 8/15/24
Completion Date 8/14/27
Dollars Obligated $544K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Chapel Hill, NC 27599, USA
Similar Awards
- Federal Grant Award Summary The University of North Carolina at Chapel Hill received a $694,987 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the project "Innovative Immunotherapeutics for Breast Cancer Treatment." The award, effective October 1, 2025, through September 30, 2028, supports research and development activities designed to advance innovative immunotherapy approaches for breast cancer...
- Federal Project Grant Award Summary The University of North Carolina at Chapel Hill received a $500,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to support a novel drug discovery approach for preventing posttraumatic osteoarthritis. The award, effective July 1, 2025 through June 30, 2027, represents a two-year research initiative conducted at UNC-CH's Chapel Hill, North Carolina location. The funding supports...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,541,280.00 to the University of North Carolina at Chapel Hill to conduct research for "The Breast Cancer Cellular Atlas" project. The award period runs from March 1, 2025 to February 28, 2029. As a prominent public research university, UNC-Chapel Hill specializes in advanced scientific investigations, clinical studies, and...
- The University of North Carolina at Chapel Hill will receive $3,863,892 under a four-year Project Grant from the Defense Health Agency to integrate molecular pathology, radiology, and genetics to improve breast cancer risk prediction. The grant, awarded on September 15, 2023 under the Military Medical Research and Development program, will support the university's efforts to transform military and public health care by investigating medical solutions for the battlefield and innovative research...
- This $489,065.00 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of North Carolina at Chapel Hill (UNC-CH) will fund research to develop potentiated chip variants as therapies for alleviating tau pathology and neurodegeneration. The award period runs from July 1, 2025 to June 30, 2028. UNC-CH, through its Office of Sponsored Research, will conduct this advanced biomedical research project, leveraging...
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,244,000.00 to the University of North Carolina at Chapel Hill to conduct research targeting the E3 ligase SPOP in treating renal cell carcinoma. The award period runs from July 1, 2024 to June 30, 2028. The University of North Carolina at Chapel Hill, a major public research university, has extensive experience managing large-scale federally-funded...
- This $311,000 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program will support the University of North Carolina at Chapel Hill (UNC-CH) in enhancing clinical trial discovery, matching, and enrollment for pancreatic ductal adenocarcinoma (PDAC) using fine-tuned large language models. The award, which runs from November 1, 2024 to October 31, 2026, will enable UNC-CH to develop innovative...
- The University of North Carolina at Chapel Hill (UNC-CH) received a $509,979 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to fund research on "Potentiated Chip Variants as Therapeutics to Alleviate Tau Pathology and Neurodegeneration." This 3-year project, with a performance period from July 1, 2025 to June 30, 2028, will focus on developing innovative medical solutions to address critical health challenges...
- Federal Project Grant Award Summary Duke University's Office of Research Administration was awarded $845,250 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) beginning July 1, 2025, through June 30, 2028. The project focuses on engineering T-cell receptor (TCR)-modified T cells designed to target human endogenous retroviruses for non-small cell lung cancer immunotherapy. This research initiative represents an advanced biomedical research...
- Federal Project Grant Award Summary Award: The Defense Health Agency (DHA), through its Military Medical Research and Development program (CFDA 12.420), awarded Duke University's Office of Research Administration a Project Grant of $564,705 on September 15, 2025, for research extending through September 14, 2028. The award supports the identification of oncofusion-interacting proteins as essential drug targets for common and rare oncofusions in rhabdomyosarcoma. This research initiative aligns...